Very impressive share price performance over the last month.
However, looking into the numbers (roughly) going forward, it looks like OGC may actually make a loss in FY 2010.
By my calcs (and I've assumed 84koz produced per quarter going forward + static operating costs, static D&A costs, & static admin costs going forward + 2/3 hedging/call options), I get total revenue of US$146m & total costs of US$148m (not including interest payments or hedge accounting losses) for FY 2010.
When adding in interest costs & fair value adjustment of remaining hedges, OGC could be running at an accounting loss.
Presumably, the D&A costs (and obviously the hedging losses) don't affect cashflow, so OGC may still be cashflow positive.
Can anyone verify my calcs?
Cheers,
Z.
- Forums
- ASX - By Stock
- OGC
- 1q09 results
1q09 results, page-10
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OGC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online